Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies

Breast

Volumn 16, Issue 2 SUPPL., 2007, Pages 55-58

  Viale, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Her2 over expression; Hormone receptor status; Intracystic papillary carcinoma; Metastases

Indexed keywords

CALDESMON; CALPONIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; LETROZOLE; MYOSIN; PROGESTERONE RECEPTOR; PROTEIN P63; TAMOXIFEN; TRASTUZUMAB;

ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG RESPONSE; FALSE NEGATIVE RESULT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

EID: 35648993429     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.07.007     Document Type: Article

References (16)

1. Lefkowitz M., Lefkowitz W., Wargotz E.S., et al. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum Pathol 25 (1994) 802-809
2. Leal C., Costa I., Fonseca D., et al. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study. Hum Pathol 29 (1998) 1097-1104
3. Maluf H.M., and Koerner F.C. Solid papillary carcinoma of the breast: a form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 19 (1995) 1237-1244
4. Nassar H., Qureshi H., and Volkan Adsay N Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30 (2006) 501-507
5. Collins L.C., Carlo V.P., Hwang H., Barry T.S., Gown A.M., and Schnitt S.J. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 30 (2006) 1002-1007
6. Carter D., Orr S.L., and Merino M.J. Intracystic papillary carcinoma of the breast: after mastectomy, radiotherapy or excisional biopsy alone. Cancer 1 (1983) 14-19
7. Solorzano C.C., Middleton L.P., Hunt K.K., et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 184 (2002) 364-368
8. van't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
9. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
10. Wang Y., Klijin J.G., Sieuwerts A.M., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
11. Sotiriou C., Wirapati P., Loi S., et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98 (2006) 262-272
12. Buyse M., Loi S., van't Veer L., et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98 (2006) 1183-1192
13. Regan M.M., Viale G., Mastropasqua M.G., et al. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. J Natl Cancer Inst 98 (2006) 1571-1581
14. Viale G. Histopathology of primary breast cancer. Breast 12 (2003) 391-396
15. Perez E.A., Suman V.J., Davidson N.E., et al. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 Intergroup adjuvant trial. J Clin Oncol 24 (2006) 3032-3038
16. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol, 2007;25:118-45.